GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guanhao Biotech Co 300238.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

10.58

-1.03%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Guanhao Biotech Co

Its shares trade on Shenzhen under the ticker 300238.SZ. It has been listed since 6 July 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥383.4m and net income of CN¥24.3m. At that date it held total assets of CN¥806.5m and shareholders' equity of CN¥570.1m.

Guanhao Biotech Co. Ltd. engages in the research, development, production, and sale of regenerative medical materials and regenerative medical implant devices. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2011-07-06. The firm primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The firm is also engaged in provision of related technological services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
6 Jul 2011
Employees
586

Leadership

Pay as last reported

  • Mr. Yongming ZhangChairman of the Board, since 2018
  • Mr. Xinzhi WangVice Chairman of the Board, since 2020
  • Mr. Ruofeng YiFinance Director
  • Mr. Weikun ZhangChief Risk Officer, Deputy General Manager
  • Mr. Feng ZhaoGeneral Manager
  • Mr. Qingrong XuDeputy General Manager, Secretary of the Board
  • Mr. Xianggui LinDeputy General Manager
  • Mr. Zhen YouDeputy General Manager
  • Ms. Junhui ZhaoExecutive Deputy General Manager, since 2020
  • Ms. Feng SunDirector
  • Mr. Chao DengIndependent Director
  • Ms. Junmei HanIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Guanhao Biotech employs 586 full-time staff members in Guangzhou.
  • The company produces biological dura mater patches for medical use.
  • Guanhao Biotech sells intraocular lenses and agent products globally.

Weaknesses

  • The firm relies on regenerative medical implant devices for revenue.
  • Guanhao Biotech operates within the specialized biotechnology industry sector.
  • The company provides related technological services alongside physical products.

Opportunities

  • Guanhao Biotech can expand sales of asepsis biological wound-surface protection membranes.
  • The firm may grow its chest general surgery department patching membranes.
  • Guanhao Biotech can develop new type B dura matrix products.

Threats

  • Guanhao Biotech faces competition in the regenerative medical materials market.
  • The company must maintain quality for biological dura mater patches.
  • Guanhao Biotech risks regulatory changes affecting intraocular lens sales.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.